Medication Assisted Treatment Program (MAT)

What is Medication Assisted Treatment?

MAT utilizes FDA-approved medications in conjunction with counseling and behavioral-based therapy to treat individuals with Opioid Use Disorder. Medications can be a tremendous help to patients, especially those in the early recovery process.

The medications used to treat OUD, Buprenorphine or Naltrexone, now only require a standard DEA license. The new requirements to apply for or renew your DEA license include the required 8 hours of SUD training.

BCBSM MAT Initiative

To help address the need for more prescribing providers, BCBSM has a MAT Initiative that provides support and incentives to providers who provide Medication Assisted Treatment to patients with Opioid Use Disorder.

Practices who treat and report at least 10 individual patients for MAT during the measurement year are eligible to receive a 10% VBR in the PGIP program (must be PCMH designated).

For more information contact BACO Practice Transformation Coordinator and initiative lead Amanda Johnson


BCBSM has partnered with Michigan Opioid Collaborative. They offer free resources; office hours, consultations with an addiction specialist, trainings, and on-demand content. Visit Michigan Opioid Collaborative to learn more.

Beaumont ACO Logo
Copyright ©  Beaumont ACO. All Rights Reserved.